期刊文献+

雌激素缺乏引起雌性SD大鼠血小板激活 被引量:2

Platelet Activation Due to Estrogen Depletion in Female SD Rats
下载PDF
导出
摘要 目的研究雌激素缺乏对雌性SD大鼠血小板聚集功能的影响及其与一氧化氮相关的作用机制。方法雌性SD大鼠随机分为假手术组、卵巢切除组以及卵巢切除补充雌激素组,分别施行假手术、卵巢切除术以及在卵巢切除术后第3天开始皮下注射补充雌激素,药物补充4周后处死动物,提取血清检测血清雌激素水平,提取富小板血浆测定血小板聚集功能,并用ELISA方法测定血浆中一氧化氮生物活性指标环磷酸鸟苷的水平。结果卵巢切除组雌性SD大鼠血清雌激素水平明显降低,雌激素补充使卵巢切除补充雌激素组动物的雌激素水平回复到假手术组状态。卵巢切除组雌性SD大鼠血小板聚集率显著升高;卵巢切除补充雌激素后血小板聚集率较前者明显回落,但仍高于假手术组聚集水平;血浆中环磷酸鸟苷水平在卵巢切除组显著下降,补充雌激素后血浆中环磷酸鸟苷水平与假手术组差异无显著性。结论雌激素缺乏会促进雌性SD大鼠的血小板聚集,其机制可能与血浆中一氧化氮/环磷酸鸟苷水平下降有关。 Aim To investigate whether estrogen deficiency may impact the platelet aggregation function in female SD rats and the underlying mechanisms relative to nitric oxide(NO).Methods Female SD rats were randomly divided into three groups: sham,ovariectomy,and ovariectomy supplemented with estrogen group.Each of them received sham operation,ovariectomy or ovariectomy followed by estrogen supplementation respectively.Estrogen supplementation started 3 days after the ovariectomy and continued for the following 4 weeks,then the animals were sacrificed.The serum was obtained to perform the estrogen assay.The platelet-rich plasma was collected to measure its platelet aggregation ability,and to detect plasma cGMP(Guanosine 3,5-cyclic monophosphate),the NO bioactive index,via the method of ELISA.Results The serum estrogen level in ovariectomized female SD rats was much lower than that in shamed animals,estrogen supplementation effectively restored the ovariectomized animals' serum estrogen.The platelets aggregation in ovariectomized rats was remarkably higher than that in shamed animals,estrogen supplementation could lower the platelets aggregation ability,though not to the sham level.The plasma cGMP level in the ovariectomized rats was significantly lower than that of shamed animals,estrogen supplementation may remarkably enhance the plasma cGMP,to a level in keeping with the sham group.Conclusion Lack of estrogen may boost the platelets aggregation in female SD rats,the mechanism might be relative to the down-regulation of NO/cGMP by estrogen depletion.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第12期971-974,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金(30770891)
关键词 雌激素 血小板 聚集 环磷酸鸟苷 Estrogen Platelet Aggregation Guanosine 3 5-cyclic monophosphate
  • 相关文献

参考文献2

二级参考文献16

  • 1International Stroke Trial Collaborative Group (IST).A randomized trial of aspirin,subcutaneous heparin both,or neither among 19435 patients with acute ischaemic stroke.Lancet,1997,349:1 569-581
  • 2Chinese Acute Stroke Trial Collaborative Group (CAST).Randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke.Lancet,1997,349:1 641-649
  • 3Lee M,Cryer B,Feldman M.Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury.Am Intern Med,1994,120:184-189
  • 4Derry S,Loke YK.Risk of gastrointestinal haemorrhage with long term use of aspirin:meta-analysis.Br Med J,2000,321:1 183-187
  • 5Wallace JL,Muscara MN,Mcknight W,Dicay M,Soldato PD,Cirino G.In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative,NCX-4016.Thromb Res,1999,93:43-50
  • 6Momi S,Emerson M,Paul W,Leone M,Mezzasoma AM,Del Soldato P,et al.Prevention of pulmonary thromboembolism by NCX-4016,a nitric oxide-releasing aspirin.Eur J Pharmacol,2000,397 (1):177-185
  • 7Kato S,Suzuki K,Ukawa H,Komoike Y,Takeuchi K.Low gastric toxicity of nitric oxide-releasing aspirin,BCX-4016,in rats with cirrhosis and arthritis.Dig Dis Sci,2001,46 (8):1 690-699
  • 8Fiorucci S,Santucci L,Gresele P,Faccino RM,Soldato PD,Morelli A.Gastrointestinal safety of NO-aspirin (NO-4016) in healthy human volunteers:a proof of concept endoscopic study.Gastroenterology,2003,124:600-607
  • 9Fiorucci S,Mencarelli A,Meneguzzi A,Lechi A,Morelli A,Del Soldato P,et al.NCX-4016 (NO-Aspirin) inhibits lipopolysaccharide induced tissue factor expression in vivo.Circulation,2002,106:3 120-125
  • 10Gaboury J,Woodman RC,Granger DN.Nitric oxide prevents leukocyte adherence:role of superxide.Am J Physiol,1993,265:H862-H867

共引文献5

同被引文献34

  • 1中华神经科学会 中华神经外科学会.各类脑血管病诊断要点.中华神经科杂志,1996,:379-380.
  • 2Lin L,Jian C,Li F,et al. Prevalence and risk factors for aspi rin resistance in elderly patients with type 2 diabetes. Interna tional Journal of Gerontology, 2011,5 : 112-116.
  • 3Richard FG, Munir P. Aspirin resistance : Effect of clinical, bi ochemical and genetic factors. Pharmacology Therapeutics 2011,130:213-225.
  • 4Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet, 2006, 9510606 616.
  • 5Whitea RE,Gerrityb R,Barmana SA,ct al. Estrogen and oxi- dative stress: A novel mechanism that may increase the risk for cardiovascular disease in women. Steroids, 2010,75: 788- 793.
  • 6Opotowsky AR, McWilliams JM, Cannon CP, et al. Gender differences in aspirin use among adults with coronary heart disease in the United States. J Gen Intern Med,2007,22:55-61.
  • 7Hovens MMC, Snoep JD, Groeneveld Y, et al. High levels of low density lipoprotein cholesterol and triglycerides and sub- optimal glycemic control predict exc vivo aspirin responsive ness in patients with type 2 diabetes. J Thromb Haemost, 2007,5 : 1562-1564.
  • 8Karepov V,Tolpina G,Kuliczkowski W,et al. Plasma triglyc- erides as predictors of platelet responsiveness to aspirin in pa tients aher first ischemic stroke. Cerebrovasc Dis, 2008,26: 272 276.
  • 9Tirnaksiz E, Pamukcu B, Ofiaz H, et al. Effect of high dose statin therapy on platelet function statins reduce aspirin-re- sistant platelet aggregation in patients with coronary heart disease. J Thromb Thrombolysis,2009,27:24-28.
  • 10Valles J, Santos MT, Fuset MP, et al. Partial inhibition of platelet thromboxane A2 Synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myo- cardial infarction. Am J Cardiol, 2007,99 : 19 25.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部